We use cookies to provide you with a better experience. By continuing to browse the site you are agreeing to our use of cookies in accordance with our Cookie Policy.
Accept
Home » Companies Must Focus on Substantial Evidence, Expert Says
Companies Must Focus on Substantial Evidence, Expert Says
September 12, 2007
Substantial evidence should be the “watchword” for companies that do not want to be cited for violating regulations by the FDA’s Division of Drug Marketing, Advertising and Communications (DDMAC), former agency Associate Chief Counsel Arnold Friede said.